Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats
- PMID: 11135057
- DOI: 10.1046/j.1523-1755.2001.00465.x
Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats
Abstract
Background: Dietary soy protein compared with casein retards disease progression in a gender-specific manner in the pcy mouse. In this model of polycystic kidney disease (PKD), kidney insulin-like growth factor-I (IGF-I) levels are elevated. The present study examined the gender-specific effects of soy protein feeding on disease and IGF-I in Han:SPRD-cy rats.
Methods: Normal (+/+) and affected (cy/+) weanling male and female Han:SPRD-cy rats were given either casein- or soy protein-based diets for six weeks. Renal size, water content, cyst size and IGF-I, serum creatinine, urea and IGF-I, and creatinine clearance were determined.
Results: Soy protein-fed cy/+ animals had lower kidney weight, water content and cyst size, lower serum urea and creatinine, and higher creatinine clearance. In cy/+ females, dietary soy protein resulted in normalized serum creatinine and creatinine clearance. Kidney IGF-I levels (ng/kidney) were 32 to 76% higher in cy/+ compared with +/+ groups (P < 0.001). Soy protein feeding resulted in lower kidney IGF-I in cy/+ males (1123 vs. 1496 ng/kidney, P < 0.001) and cy/+ females (816 vs. 943 ng/kidney, P < 0.05). In males, soy protein feeding resulted in lower serum IGF-I concentrations in +/+ (1439 vs. 1708 ng/mL, P < 0.05) and in cy/+ (1483 vs. 2073 ng/mL, P < 0.001) animals.
Conclusions: Dietary soy protein compared with casein delays the progression of disease in male and female Han:SPRD-cy rats. Overall, IGF-I was lower in +/+ animals, in females, and in animals consuming the soy protein diet, supporting a role for IGF-I in the pathogenesis of disease in the Han:SPRD-cy rat and an ameliorating role for dietary soy protein.
Similar articles
-
[Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].Srp Arh Celok Lek. 2002 Jul-Aug;130(7-8):251-7. Srp Arh Celok Lek. 2002. PMID: 12585002 Serbian.
-
Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD-Cy rat.Mol Nutr Food Res. 2014 Apr;58(4):768-81. doi: 10.1002/mnfr.201300332. Epub 2013 Oct 30. Mol Nutr Food Res. 2014. PMID: 24170691
-
Dietary soy protein benefit in experimental kidney disease is preserved after isoflavone depletion of diet.Exp Biol Med (Maywood). 2010 Nov;235(11):1315-20. doi: 10.1258/ebm.2010.010059. Epub 2010 Oct 4. Exp Biol Med (Maywood). 2010. PMID: 20921276
-
Evidence for a role of proteins, lipids, and phytochemicals in the prevention of polycystic kidney disease progression and severity.Nutr Rev. 2013 Dec;71(12):802-14. doi: 10.1111/nure.12085. Epub 2013 Nov 18. Nutr Rev. 2013. PMID: 24246056 Review.
-
Rat models of autosomal dominant polycystic kidney disease.Nephrol Dial Transplant. 1996;11 Suppl 6:46-51. doi: 10.1093/ndt/11.supp6.46. Nephrol Dial Transplant. 1996. PMID: 9044328 Review.
Cited by
-
Sirolimus therapy to halt the progression of ADPKD.J Am Soc Nephrol. 2010 Jun;21(6):1031-40. doi: 10.1681/ASN.2009121302. Epub 2010 May 13. J Am Soc Nephrol. 2010. PMID: 20466742 Free PMC article. Clinical Trial.
-
Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis.JCI Insight. 2020 Feb 27;5(4):e135700. doi: 10.1172/jci.insight.135700. JCI Insight. 2020. PMID: 31990681 Free PMC article.
-
Lack of Benefit of Early Intervention with Dietary Flax and Fish Oil and Soy Protein in Orthologous Rodent Models of Human Hereditary Polycystic Kidney Disease.PLoS One. 2016 May 23;11(5):e0155790. doi: 10.1371/journal.pone.0155790. eCollection 2016. PLoS One. 2016. PMID: 27213553 Free PMC article.
-
Wheat-Based Protein Slows Disease Progression in Pkd1 Knockout Mice.Function (Oxf). 2025 Aug 1;6(4):zqaf026. doi: 10.1093/function/zqaf026. Function (Oxf). 2025. PMID: 40493450 Free PMC article.
-
The pathobiology of polycystic kidney disease from a metabolic viewpoint.Nat Rev Nephrol. 2019 Dec;15(12):735-749. doi: 10.1038/s41581-019-0183-y. Epub 2019 Sep 5. Nat Rev Nephrol. 2019. PMID: 31488901 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical